C

Curis
D

CRIS

4.15000
USD
0.45
(12.13%)
مغلق
حجم التداول
0
الربح لكل سهم
-7
العائد الربحي
-
P/E
-1
حجم السوق
24,812,622
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    B
    BNTC
    0.130
    (1.25%)
    10.500 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    N
    NTLA
    -1.165
    (-7.71%)
    13.955 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    S
    SGMO
    -0.10000
    (-4.67%)
    2.04000 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    450.63 USD
    المزيد
الأخبار

العنوان: Curis

القطاع: Healthcare
الصناعة: Biotechnology
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advancedsolid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.